United States Biotechnology & Medical Research

Emerald Bioscience Inc (EMBI)

Track

Stock chart
Ticker: EMBI Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
5AM Partners VII, LLC
2 sales — total 582,936 USD
Sale 22 Aug 2025
Value US$381,157.15 | Price 83.34 | Shares 48,267
Sale 22 Aug 2025
Value US$4,757,506.86 | Price 121.72 | Shares 29,923
Sale 22 Aug 2025
Value US$4,064,132.39 | Price 45.84 | Shares 31,156
Sale 22 Aug 2025
Value US$487,086.07 | Price 138.58 | Shares 67,062
Sale 21 Aug 2025
Value US$8,260.98 | Price 3.57 | Shares 2,314
Sale 21 Aug 2025
Value US$209,351.94 | Price 3.57 | Shares 58,642
Sale 21 Aug 2025
Value US$8,260.98 | Price 3.57 | Shares 2,314
Sale 21 Aug 2025
Value US$209,351.94 | Price 3.57 | Shares 58,642
Sale 18 Nov 2024
Value US$97,250.11 | Price 4.99 | Shares 19,489
Sale 18 Nov 2024
Value US$215,597.94 | Price 4.99 | Shares 43,206
Sale 18 Nov 2024
Value US$411,904.54 | Price 4.99 | Shares 82,546
Sale 18 Nov 2024
Value US$430,357.56 | Price 4.99 | Shares 86,244
Sale 15 Nov 2024
Value US$471.75 | Price 5.55 | Shares 85
Proposed sale 15 Nov 2024
Value US$126,052.27 | Price 5.51 | Shares 22,877
Sale 15 Nov 2024
Value US$1,054.50 | Price 5.55 | Shares 190
Proposed sale 15 Nov 2024
Value US$314,532.84 | Price 5.51 | Shares 57,084
Sale 15 Nov 2024
Value US$2,020.20 | Price 5.55 | Shares 364
Proposed sale 15 Nov 2024
Value US$554,818.43 | Price 5.51 | Shares 100,693
Sale 15 Nov 2024
Value US$1,703.85 | Price 5.55 | Shares 307
Proposed sale 15 Nov 2024
Value US$478,290.00 | Price 5.51 | Shares 86,804
Sale 13 Sep 2024
Value US$478.74 | Price 6.06 | Shares 79
Sale 13 Sep 2024
Value US$12,120.00 | Price 6.06 | Shares 2,000
Sale 13 Sep 2024
Value US$71,253.48 | Price 6.06 | Shares 11,758
Sale 13 Sep 2024
Value US$478.74 | Price 6.06 | Shares 79
Sale 13 Sep 2024
Value US$12,120.00 | Price 6.06 | Shares 2,000
Sale 13 Sep 2024
Value US$71,253.48 | Price 6.06 | Shares 11,758
Sale 11 Sep 2024
Value US$9,504.00 | Price 6.60 | Shares 1,440
Sale 11 Sep 2024
Value US$240,926.40 | Price 6.60 | Shares 36,504
Sale 11 Sep 2024
Value US$1,416,069.60 | Price 6.60 | Shares 214,556
Sale 11 Sep 2024
Value US$9,504.00 | Price 6.60 | Shares 1,440
Sale 11 Sep 2024
Value US$240,926.40 | Price 6.60 | Shares 36,504
Sale 11 Sep 2024
Value US$1,416,069.60 | Price 6.60 | Shares 214,556
Buy 13 Mar 2024
Value US$4,500,000.00 | Price 10.00 | Shares 450,000
Buy 31 Jan 2024
Value US$12,026,030.94 | Price 2.31 | Shares 5,206,074
Buy 29 Aug 2023
Value US$16,474.70 | Price 0.02 | Shares 881,000
Buy 16 Feb 2018
Value US$0.00 | Price 0.00 | Shares 15,000,000
Sale 10 Apr 2015
Value US$58,310.07 | Price 4.93 | Shares 11,830
Sale 8 Apr 2015
Value US$75,682.00 | Price 4.79 | Shares 15,800
Sale 8 Apr 2015
Value US$107,893.00 | Price 4.69 | Shares 23,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
48,267 +4.6%
83.34
US$381,157 		48,267 +4.6% 83.34 US$381,157
2025-08-22 2025-08-22 S Sale
5AM Partners VII, LLC
Large shareholder
29,923 +47.0%
121.72
US$4,757,507 		29,923 +47.0% 121.72 US$4,757,507
2025-08-22 2025-08-22 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
31,156 -36.0%
45.84
US$4,064,132 		31,156 -36.0% 45.84 US$4,064,132
2025-08-22 2025-08-22 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
163,979 -10.1%
3.42
US$560,808 		163,979 -10.1% 3.42 US$560,808
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
5AM Partners VII, LLC
Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2025-08-22 2025-08-21 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
2,314 -3.5%
3.57
US$8,261 		2,314 -3.5% 3.57 US$8,261
2025-08-22 2025-08-21 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
58,642 -3.5%
3.57
US$209,352 		58,642 -3.5% 3.57 US$209,352
2024-11-20 2024-11-18 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
19,489 -19.2%
4.99
US$97,250 		19,489 -19.2% 4.99 US$97,250
2024-11-19 2024-11-18 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
43,206 -20.6%
4.99
US$215,598 		43,206 -20.6% 4.99 US$215,598
2024-11-19 2024-11-18 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
82,546 -20.0%
4.99
US$411,905 		82,546 -20.0% 4.99 US$411,905
2024-11-19 2024-11-18 S Sale
Grayson Paul A.
Non-Executive Director
86,244 -24.9%
4.99
US$430,358 		86,244 -24.9% 4.99 US$430,358
2024-11-20 2024-11-15 S Sale
Diep Tuan Tu

Chief Development Officer

Officer
85 -0.1%
5.55
US$472 		85 -0.1% 5.55 US$472
2024-11-19 2024-11-15 S Sale
ARSENAULT KAITLYN

Chief Financial Officer

Officer
190 -0.1%
5.55
US$1,054 		190 -0.1% 5.55 US$1,054
2024-11-19 2024-11-15 S Sale
DHILLON PUNIT

Chief Executive Officer

Executive Director
364 -0.1%
5.55
US$2,020 		364 -0.1% 5.55 US$2,020
2024-11-19 2024-11-15 S Sale
Grayson Paul A.
Non-Executive Director
307 -0.1%
5.55
US$1,704 		307 -0.1% 5.55 US$1,704
2024-11-15 2024-11-15 PrS Proposed sale
ARSENAULT KAITLYN

Officer

Officer
57,084
5.51
US$314,533 		57,084 5.51 US$314,533
2024-11-15 2024-11-15 PrS Proposed sale
DHILLON PUNIT

Officer; Director

Executive Director
100,693
5.51
US$554,818 		100,693 5.51 US$554,818
2024-11-15 2024-11-15 PrS Proposed sale
Diep Tuan Tu

Officer

Officer
22,877
5.51
US$126,052 		22,877 5.51 US$126,052
2024-11-15 2024-11-15 PrS Proposed sale
Grayson Paul A.

Director

Non-Executive Director
86,804
5.51
US$478,290 		86,804 5.51 US$478,290
2024-09-13 2024-09-13 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
79 -0.1%
6.06
US$479 		79 -0.1% 6.06 US$479
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
2,000 -0.1%
6.06
US$12,120 		2,000 -0.1% 6.06 US$12,120
2024-09-13 2024-09-13 S Sale
5AM Partners VII, LLC
Large shareholder
11,758 -0.1%
6.06
US$71,253 		11,758 -0.1% 6.06 US$71,253
2024-09-13 2024-09-11 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
1.2
Schwab Andrew J.
Non-Executive Director Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
1,440 -2.1%
6.60
US$9,504 		1,440 -2.1% 6.60 US$9,504
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
36,504 -2.1%
6.60
US$240,926 		36,504 -2.1% 6.60 US$240,926
2024-09-13 2024-09-11 S Sale
5AM Partners VII, LLC
Large shareholder
214,556 -2.6%
6.60
US$1,416,070 		214,556 -2.6% 6.60 US$1,416,070
2024-03-15 2024-03-13 B Purchase
5AM Partners VII, LLC
Large shareholder
450,000 +5.7%
10.00
US$4,500,000 		450,000 +5.7% 10.00 US$4,500,000
2024-02-02 2024-01-31 B Purchase
5AM Partners VII, LLC
Large shareholder
5,206,074 +190.2%
2.31
US$12,026,031 		5,206,074 +190.2% 2.31 US$12,026,031
2023-08-29 2023-08-29 B Purchase
DHILLON PUNIT

Chief Executive Officer

Executive Director
881,000 +2.2%
0.02
US$16,475 		881,000 +2.2% 0.02 US$16,475
2018-02-21 2018-02-16 B Purchase Emerald Health Sciences Inc. Large shareholder
15,000,000
0.00
US$0 		15,000,000 0.00 US$0
2015-04-10 2015-04-10 S Sale Ladin Brian D Large shareholder
11,830 -4.5%
4.93
US$58,310 		11,830 -4.5% 4.93 US$58,310
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
15,800 -5.7%
4.79
US$75,682 		15,800 -5.7% 4.79 US$75,682
2015-04-10 2015-04-08 S Sale Ladin Brian D Large shareholder
23,000 -7.7%
4.69
US$107,893 		23,000 -7.7% 4.69 US$107,893
Explore more

More insider trading research around Emerald Bioscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America